Cigna Group $CI Shares Bought by Banyan Capital Management Inc.

Banyan Capital Management Inc. boosted its stake in shares of Cigna Group (NYSE:CI) by 4.1% during the 1st quarter, Holdings Channel reports. The firm owned 62,556 shares of the health services provider’s stock after acquiring an additional 2,482 shares during the quarter. Cigna Group comprises approximately 7.2% of Banyan Capital Management Inc.’s investment portfolio, making the stock its 4th largest position. Banyan Capital Management Inc.’s holdings in Cigna Group were worth $16,687,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of CI. Wilkerson Advisory Group LLC purchased a new stake in shares of Cigna Group during the fourth quarter valued at $25,000. Beacon Financial Strategies CORP purchased a new position in Cigna Group in the 4th quarter worth $28,000. Cedar Mountain Advisors LLC lifted its position in Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock worth $29,000 after acquiring an additional 68 shares during the period. Kemnay Advisory Services Inc. acquired a new stake in Cigna Group during the 4th quarter worth about $29,000. Finally, Prosperity Bancshares Inc purchased a new stake in Cigna Group during the 4th quarter valued at about $29,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Buying and Selling

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction on Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer owned 34,337 shares in the company, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

CI has been the subject of several research analyst reports. Barclays cut Cigna Group from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $310.00 to $304.00 in a research note on Tuesday, May 26th. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, June 20th. The Goldman Sachs Group raised their price target on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Sanford C. Bernstein lifted their price objective on shares of Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a research note on Thursday. Finally, Robert W. Baird set a $337.00 price objective on shares of Cigna Group in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $338.80.

Cigna Group Price Performance

Shares of Cigna Group stock traded up $1.56 during trading hours on Friday, reaching $293.36. The stock had a trading volume of 761,525 shares, compared to its average volume of 1,479,583. The stock’s 50 day moving average is $285.67 and its 200 day moving average is $279.73. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The firm has a market capitalization of $77.60 billion, a PE ratio of 12.44, a PEG ratio of 1.13 and a beta of 0.29.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. During the same period last year, the firm earned $6.74 EPS. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities analysts expect that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th were given a $1.56 dividend. The ex-dividend date was Thursday, June 4th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. Cigna Group’s payout ratio is 26.45%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.